middle-income

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

AMSTERDAM, Nov. 19, 2024 /PRNewswire/ -- The 2024 Access to Medicine Index finds that pharmaceutical companies are not fully leveraging…

6 months ago